Abstract
The new technology of tandem mass spectrometry is having a significant impact on the diagnostics of inborn metabolic errors. One of the most important aspects of this new technology is the possibility of recognising a whole class of disorders within a single analytical step. Shall this powerful technology be applied to the screening of newborn babies? Careful evaluation of every single disorder that could potentially be identified is needed. In the following, I will present some considerations that concern glutaric aciduria type 1 (MIM 231670; glutaryl-CoA dehydrogenase deficiency).
Similar content being viewed by others
Abbreviations
- GADH :
-
glutaryl-CoA dehydrogenase
- GA1 :
-
glutaric aciduria type 1
- TMS :
-
tandem mass spectrometry
References
Altman NR, Rovira MJ, Bauer M (1991) Glutaric aciduria type 1: MR findings in two cases. AJNR 12: 966–968
Baric I, Zschocke J, Christensen E, Duran M, Goodman SI, Leonard JV, Muller E, Morton DH, Superti-Furga A, Hoffmann GF (1998) Diagnosis and management of glutaric aciduria type I. J Inherit Metab Dis 21: 326–340
Brandt NJ, Gregersen N, Christensen E, Rasmussen K (1978) Glutaric aciduria in two brothers. J Inherit Metab Dis 1: 13–14
Brandt NJ, Gregersen N, Christensen E, Gron IH, Rasmussen K (1979) Treatment of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria). Experience with diet, riboflavin, and GABA analogue. J Pediatr 94: 669–673
Brismar J, Ozand PT (1994) CT and MR of the brain in the diagnosis of organic acidemias. Experiences from 107 patients. Brain Dev 16[Suppl]: 104–124
Collins J, Leonard JV (2000) Natural history of glutaric aciduria type 1. Arch Dis Child 83: 87
Drigo P, Burlina AB, Battistella PA (1993) Subdural hematoma and glutaric aciduria type 1. Brain Dev 15: 460–461
Greenberg CR, Prasad AN, Dilling LA, Thompson JR, Haworth JC, Martin B, Wood-Steiman P, Seargeant LE, Seifert B, Booth FA, Prasad C (2002) Outcome of the first 3 years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada. Mol Genet Metab 75: 70–78
Haworth JC, Booth FA, Chudley AE, de Groot GW, Dilling LA, Goodman SI, Greenberg CR, Mallory CJ, McClarty BM, Seshia SS et al (1991) Phenotypic variability in glutaric aciduria type I: report of fourteen cases in five Canadian Indian kindreds. J Pediatr 118: 52–58
Hoffmann GF, Zschocke J (1999) Glutaric aciduria type I: from clinical, biochemical and molecular diversity to successful therapy. J Inherit Metab Dis 22: 381–391
Hoffmann GF, Trefz FK, Barth PG, Böhles HJ, Biggemann B, Bremer HJ, Christensen E, Frosch M, Hanefeld F, Hunneman DH et al (1991) Glutaryl-coenzyme A dehydrogenase deficiency: a distinct encephalopathy. Pediatrics 88: 1194–1203
Hoffmann GF, Athanassopoulos S, Burlina AB, Duran M, de Klerk JB, Lehnert W, Leonard JV, Monavari AA, Muller E, Muntau AC, Naughten ER, Plecko-Starting B, Superti-Furga A, Zschocke J, Christensen E (1996) Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics 27: 115–123
Kohler M, Hoffmann GF (1998) Subdural haematoma in a child with glutaric aciduria type I. Pediatr Radiol 28: 582
Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GF (1999) 3-Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro. J Inherit Metab Dis 22: 259–262
Kolker S, Ahlemeyer B, Krieglstein J, Hoffmann GF (2000) Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA dehydrogenase deficiency. Pediatr Res 47: 495–503
Kolker S, Ramaekers VT, Zschocke J, Hoffmann GF (2001) Acute encephalopathy despite early therapy in a patient with homozygosity for E365K in the glutaryl-coenzyme A dehydrogenase gene. J Pediatr 138: 277–279
Kolker S, Kohr G, Ahlemeyer B, Okun JG, Pawlak V, Horster F, Mayatepek E, Krieglstein J, Hoffmann GF (2002) Ca(2+) and Na(+) dependence of 3-hydroxyglutarate-induced excitotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 52: 199–206
Kolker S, Okun JG, Ahlemeyer B, Wyse AT, Horster F, Wajner M, Kohlmuller D, Mayatepek E, Krieglstein J, Hoffmann GF (2002) Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalons. J Neurosci Res 68: 424–431
Lopez AD, Murray CC (1998) The global burden of disease, 1990–2020. Nat Med 4: 1241–1243
Lutcherath V, Waaler PE, Jellum E, Wester K (2000) Children with bilateral temporal arachnoid cysts may have glutaric aciduria type 1 (GAT1); operation without knowing that may be harmful. Acta Neurochir (Wien) 142: 1025–1030
Mandel H, Braun J, Elpeleg O, Christensen E, Berant M (1991) Glutaric aciduria type I. Brain CT features and a diagnostic pitfall. Neuroradiology 33: 75–78
Martinez-Lage JF, Casas C, Fernandez MA, Puche A, Rodriguez-Costa T, Poza M (1994) Macrocephaly, dystonia, and bilateral temporal arachnoid cysts: glutaric aciduria type 1. Childs Nerv Syst 10: 198–203
Monavari AA, Naughten ER (2000) Prevention of cerebral palsy in glutaric aciduria type 1 by dietary management. Arch Dis Child 82: 67–70
Naylor EW, Chace DH (1999) Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism. J Child Neurol 14[Suppl 1]: S4–S8
Niiyama S, Koelker S, Degen I, Hoffmann GF, Happle R, Hoffmann R (2001) Acrodermatitis acidemica secondary to malnutrition in glutaric aciduria type I. Eur J Dermatol 11: 244–246
Osaka H, Kimura S, Nezu A, Yamazaki S, Saitoh K, Yamaguchi S (1993) Chronic subdural hematoma as an initial manifestation of glutaric aciduria type 1. Brain Dev 15: 125–127
Schwappach DL (2002) Resource allocation, social values and the QALY: a review of the debate and empirical evidence. Health Expect 5: 210–222
Superti-Furga A, Hoffmann GF (1997) Glutaric aciduria type 1 (glutaryl-CoA-dehydrogenase deficiency): advances and unanswered questions. Report from an international meeting. Eur J Pediatr 156: 821–828
Thomason MJ, Lord J, Bain MD, Chalmers RA, Littlejohns P, Addison GM, Wilcox AH, Seymour CA (1998) A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism. J Public Health Med 20: 331–343
Tilford JM (2002) Cost-effectiveness analysis and emergency medical services for children: issues and applications. Ambul Pediatr 2: 330–336
Trefz FK, Hoffmann GF, Mayatepek E, Lichter-Konecki U, Weisser J, Otten A, Wendel U, Rating D, Bremer HJ (1991) Macrocephaly as the initial manifestation of glutaryl-CoA-dehydrogenase deficiency (glutaric aciduria type I). Monatsschr Kinderheilkd 139: 754–758
Ullrich K, Flott-Rahmel B, Schluff P, Musshoff U, Das A, Lucke T, Steinfeld R, Christensen E, Jakobs C, Ludolph A, Neu A, Roper R (1999) Glutaric aciduria type I: pathomechanisms of neurodegeneration. J Inherit Metab Dis 22: 392–403
Wilson JM and Jungner YG (1968) Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 65: 281–393
Woelfle J, Kreft B, Emons D, Haverkamp F (1996) Subdural hemorrhage as an initial sign of glutaric aciduria type 1: a diagnostic pitfall. Pediatr Radiol 26: 779–781
Acknowledgements
I am grateful to Drs. Cheryl Greenberg, Georg Hoffmann, Ania Muntau, Adelbert Roscher, Bridget Wilcken, and several members of the Metab-L E-mail community for sharing their thoughts and experiences on glutaric aciduria and neonatal screening.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Superti-Furga, A. Glutaric aciduria type 1 and neonatal screening: time to proceed—with caution. Eur J Pediatr 162 (Suppl 1), S17–S20 (2003). https://doi.org/10.1007/s00431-003-1344-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-003-1344-2